secwatch.observer — SEC 8-K summary
======================================

Issuer:     Penumbra Inc (PEN)
CIK:        0001321732
Form:       8-K
Filed at:   2025-02-18T23:59:59+00:00
Accession:  0001321732-25-000010
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Penumbra Q4 adjusted revenue $321.3M (+13%); U.S. thrombectomy up 27%
---------------------------------------------------------------------

- Adjusted revenue (excl. Italian payback) Q4 $321.3M, up 12.9% YoY; reported revenue $315.5M (+10.8%).
- GAAP net income Q4 $33.7M (10.7% margin); full-year net income $14.0M.
- Adjusted EBITDA Q4 $63.7M (19.8% margin); full-year $171.0M (14.2% margin).
- U.S. thrombectomy products grew 27.3% in Q4; international thrombectomy revenue declined 13.9% adjusted.
- Full-year adjusted revenue $1,200.4M, up 13.4% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321732/000132173225000010/0001321732-25-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321732/000132173225000010/pen-20250218.htm
  HTML page:      https://secwatch.observer/filing/0001321732-25-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer